Their findings revealed a significant increase in granzyme B levels and a significant increase in granzyme B and IFN-γ secretion upon targeting CD7-positive primary T-ALL cells, along with the substantial suppression of disease progression in a T-ALL mouse xenograft model. Here, GZMB is linked to acute lymphoblastic leukemia.